Heka VR is a virtual reality platform that utilizes real-time voice modulation to provide evidence-based therapy for individuals experiencing auditory hallucinations, particularly those with treatment-resistant schizophrenia. By creating a controlled and immersive environment, Heka VR empowers patients to confront and manage their symptoms effectively.
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Individuals with treatment-resistant schizophrenia often experience persistent auditory hallucinations that significantly impair their daily functioning and quality of life. Current treatments may not fully alleviate these symptoms, leaving patients struggling to manage distressing voices and sounds.
Solution
Heka VR provides a virtual reality (VR) platform designed to help individuals manage auditory hallucinations through simulation training. The platform uses real-time voice modulation within an immersive VR environment to allow patients to confront and interact with simulated voices in a controlled, therapeutic setting. This approach aims to empower patients by providing them with tools and strategies to counter and reduce the impact of auditory hallucinations on their mental well-being. By practicing coping mechanisms in a safe virtual space, patients can develop confidence and skills to manage their symptoms in real-world situations. The VR simulations are designed based on evidence-based therapeutic principles.
Target Audience
The primary target audience includes mental health professionals, such as psychiatrists and therapists, who treat patients with treatment-resistant schizophrenia, as well as hospitals and clinics specializing in mental health care.
Features
- Immersive VR environment for realistic simulation of auditory hallucinations
- Real-time voice modulation to customize the characteristics of simulated voices
- Customizable scenarios to address specific triggers and challenges
- Biofeedback integration to monitor patient responses and adjust therapy accordingly
- Data tracking and analytics to measure progress and personalize treatment plans